Trial Profile

Health-Related Quality of Life Assessment And Communication During 48 Weeks Of Treatment Of Psoriasis Patients With Etanercept.

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 26 Jun 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etanercept (Primary)
Indications Psoriasis
Focus Therapeutic Use

Most Recent Events

22 Jun 2012 Actual initiation date (Oct 2008) added as reported by Netherlands Trial Register.
22 Jun 2012 Planned end date changed from 30 Sep 2011 to 31 Dec 2012 as reported by Netherlands Trial Register.
22 Jun 2012 Status changed from planning to recruiting as reported by Netherlands Trial Register.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com